Sabra Health Care REIT (SBRA) FY2022 results: revenue $625 million, up 9.7% on the year
Sabra Health Care REIT, Inc. (SBRA) reported revenue of $625 million for fiscal 2022, the year ended 31 December 2022, up 9.7% on the year before. Net income was -$78 million, and diluted earnings per share $-0.34. The figures are the company's own, from the 10-K it filed with the SEC on 21 February 2023.
Revenue
$625 million
+9.7% on the year
FY2015FY2022
Operating margin
n/a
FY2015FY2022
Net income
-$78 million
FY2015FY2022
Diluted EPS
-$0.34
FY2015FY2022
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Operating cash flow
316
356
355
-11.4%
Cash from investing
-216
-336
-136
Cash from financing
-162
30.1
-202
Depreciation and amortisation
188
179
177
+4.9%
Share-based compensation
7.5
7.9
7.9
-5.8%
Dividends paid
277
263
278
+5.4%
Dividend per share
$1.20
$1.20
$1.35
0.0%
Diluted shares, weighted
231m
219m
207m
+5.4%
Shares outstanding at period end
231m
230m
211m
+0.3%
Balance sheet
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Shareholders' equity
3,056
3,380
3,409
-9.6%
Debt
2,507
2,394
2,372
+4.7%
Other liabilities
185
193
204
-4.3%
Total liabilities and equity
5,748
5,967
5,986
-3.7%
Intangible assets
40.1
54.1
82.8
-25.8%
Cash and equivalents
49.3
112
59.1
-56.0%
Other assets
5,658
5,801
5,844
-2.5%
Total assets
5,748
5,967
5,986
-3.7%
10-K for the year ended 31 December 2022, filed 21 February 2023: the filing.